Data as of 3:59pm ET
| +0.04 / +0.55%|
The 9 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 8.00. The median estimate represents a +92.04% increase from the last price of 7.29.
The current consensus among 9 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.